Lefetamine

This classification denotes an analgesic agent with the molecular formula C16H19N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4J9726V5Y9, chemically known as 1-dimethylamino-1,2-diphenylethane but generally known as lefetamine, which bears US NIH Compound Identifier 22779. European Medicines Agency schedules Lefetamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08423MIG. The term LEFETAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). LEFETAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lefetamine under HS 29214600 and SITC kg. As of Q4 2014, LEFETAMINE remains the US FDA Preferred Term for this commodity. Lefetamine bears US NLM identifiers UMLS ID C0064766 and NCI Concept Code C81381. SMILES: N(C(CC1CCCCC1)C1CCCCC1)(C)C.